DMB220

inhibits Dengue virus RNA-dependent RNA polymerase; structure in first source

Also Known As:

5-benzenesulfonylmethyl-3-hydroxy-4-hydroxymethylpyridine-2-carboxylic acid hydroxyamide

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

1.	Colby-Germinario, Susan P: 1 article (01/2016)
2.	Han, Yingshan: 1 article (01/2016)
3.	Hassounah, Said: 1 article (01/2016)
4.	Oliveira, Maureen: 1 article (01/2016)
5.	Quashie, Peter K: 1 article (01/2016)
6.	Stranix, Brent R: 1 article (01/2016)
7.	Wainberg, Mark A: 1 article (01/2016)
8.	Xu, Hong-Tao: 1 article (01/2016)

1.	Infections 01/01/2016 - "The antiviral activity of DMB220 against DENV infection was also verified in a cell-based assay and showed a 50% effective concentration (EC50) of <3 μM. "

1.	Antiviral Agents (Antivirals)